Cargando…
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Autores principales: | Zhang, Hao, Luo, Minna, Liang, Xi, Wang, Dan, Gu, Xin, Duan, Chao, Gu, Huizi, Chen, Guanglei, Zhao, Xinhan, Zhao, Zuowei, Liu, Caigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162513/ https://www.ncbi.nlm.nih.gov/pubmed/32298386 http://dx.doi.org/10.1371/journal.pone.0232166 |
Ejemplares similares
-
Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2014) -
Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021) -
Expression and clinicopathological significance of FSIP1 in breast cancer
por: Zhang, Hao, et al.
Publicado: (2015) -
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Publicado: (2015) -
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2014)